Recently, the first "zoofarming" product has reached market
approval: it is a recombinant human protein for medical use that is
produced in the milk of transgenic goats. In addition, other transgenic
animals, including faster-growing salmon and „environmentally
friendly" pigs with reduced levels of phosphate in their feces are
awaiting regulatory approval. These are only some examples of upcoming
applications of genetic engineering in farm animals. Other potential
applications include traditional breeding goals such as higher milk or
meat yields, leaner meat, and disease resistance. While genetic
engineering in livestock opens a huge range of possibilities, it also
brings about concerns of safety and justification: does genetic
engineering affect animal welfare? Is it safe and morally acceptable to
apply genetic engineering to farm animals for the various purposes
that are envisaged?
It is against this background that the Europäische Akademie GmbH and the Berlin-Brandenburgische Akademie der Wissenschaften addressed the topic of transgenic farm animals in an interdisciplinary symposium in 2007. In these proceedings the following topics are covered: an analysis of the state of the art of the technology and its applications, an introduction to the specific application zoopharming (including its historical industrial development and the market for biopharmaceuticals), an assessment of ethical aspects, and considerations regarding the investigation of animal welfare implications of livestock biotechnology. The proceedings address science, industry, politics and the general public interested in the chances and risks of this upcoming field of biotechnology.
It is against this background that the Europäische Akademie GmbH and the Berlin-Brandenburgische Akademie der Wissenschaften addressed the topic of transgenic farm animals in an interdisciplinary symposium in 2007. In these proceedings the following topics are covered: an analysis of the state of the art of the technology and its applications, an introduction to the specific application zoopharming (including its historical industrial development and the market for biopharmaceuticals), an assessment of ethical aspects, and considerations regarding the investigation of animal welfare implications of livestock biotechnology. The proceedings address science, industry, politics and the general public interested in the chances and risks of this upcoming field of biotechnology.
No comments:
Post a Comment